FDA Outlines Prescription Drug Labeling for Geriatric Patients

Drugs and biologics may fit into one of four categories when it comes to their use in patients age 65 and up, the FDA says in a new draft guidance on geriatric information for prescription product labeling.
Source: Drug GMP Report